Labeler
Padagis US LLC NDC Codes
Padagis US LLC lists 63 finished drug products in the FDA NDC Directory under NDC labeler code 0574.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lenalidomide, Tretinoin, hydromorphone hydrochloride, Methylphenidate Transdermal System, Morphine Sulfate, Loteprednol Etabonate, Podofilox, benazepril hydrochloride and hydrochlorothiazide, methazolamide, Testosterone Cypionate, Belladonna and Opium, Hydrocortisone Acetate, Tofacitinib Citrate, Spironolactone, Brinzolamide
- Active ingredients
- Lenalidomide, Tretinoin, Hydromorphone hydrochloride, Methylphenidate, Morphine sulfate, Loteprednol etabonate, Podofilox, Activated charcoal, Benazepril hydrochloride, Hydrochlorothiazide, Methazolamide, Testosterone cypionate
- NDC labeler codes
- 0574
- Strengths
- Activated charcoal 208 mg/mL; Benazepril hydrochloride 20 mg/1; Tretinoin .25 mg/g; Testosterone cypionate 200 mg/mL; Atropa belladonna 16.2 mg/1; Tofacitinib citrate 11 mg/1; Loteprednol etabonate 2 mg/mL; Lenalidomide 2.5 mg/1; Lenalidomide 5 mg/1; Lenalidomide 10 mg/1; Lenalidomide 15 mg/1; Lenalidomide 20 mg/1; Lenalidomide 25 mg/1; Loteprednol etabonate 5 mg/mL; Podofilox 5 mg/g; Spironolactone 25 mg/5mL; Brinzolamide 10 mg/mL; Methylphenidate 55 mg/mg; Methylphenidate 27.5 mg/mg; Methylphenidate 41.3 mg/mg
- Dosage forms
- Suppository, Capsule, Tablet, Suspension/ drops, Gel, Patch, Cream, Tablet, Extended release, Suspension, Syrup, Injection, Solution, Tablet, Film coated, Tablet, Film coated, Extended release, Spray, Capsule, Extended release, Injection, Lozenge, Solution, Powder, Tincture
- Routes
- Oral, Rectal, Topical, Transdermal, Ophthalmic, Intramuscular, Intravenous
- Drug classes (FDA established)
- Opioid Agonist, Corticosteroid, Thalidomide Analog, Retinoid, Central Nervous System Stimulant, Cholinergic Muscarinic Antagonist, Amide Local Anesthetic, Angiotensin Converting Enzyme Inhibitor, Thiazide Diuretic, Androgen, Janus Kinase Inhibitor, Aldosterone Antagonist, Carbonic Anhydrase Inhibitor, Antiarrhythmic, Aminoglycoside Antibacterial, Serotonin Reuptake Inhibitor, Estrogen, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, alpha-Adrenergic Agonist, Ergot Derivative, Antidote, Antidote for Acetaminophen Overdose, Mucolytic, Potassium-sparing Diuretic, Azole Antifungal, Benzodiazepine, Phenothiazine, Polyene Antifungal, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Stimulant Laxative
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 92
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Tofacitinib Citrate | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | 0574-1811 | 00574-1811-30 | — |
| Loteprednol Etabonate | Loteprednol etabonate 2 mg/mL | Suspension/ dropsOphthalmic | 0574-4080 | 00574-4080-0500574-4080-10 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 0574-1402 | 00574-1402-28 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 0574-1405 | 00574-1405-28 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 0574-1410 | 00574-1410-28 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 0574-1415 | 00574-1415-21 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 0574-1420 | 00574-1420-21 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 0574-1425 | 00574-1425-21 | — |
| Loteprednol Etabonate | Loteprednol etabonate 5 mg/mL | Suspension/ dropsOphthalmic | 0574-4135 | 00574-4135-0500574-4135-1000574-4135-15 | — |
| Podofilox | Podofilox 5 mg/g | GelTopical | 0574-0621 | 00574-0621-05 | — |
| Spironolactone | Spironolactone 25 mg/5mL | SuspensionOral | 0574-1133 | 00574-1133-0400574-1133-1000574-1133-16 | — |
| Brinzolamide | Brinzolamide 10 mg/mL | Suspension/ dropsOphthalmic | 0574-4012 | 00574-4012-1000574-4012-15 | — |
| Methylphenidate Transdermal Systemmethylphenidate | Methylphenidate 55 mg/mg | PatchTransdermal | 0574-2420 | 00574-2420-65 | — |
| Methylphenidate Transdermal Systemmethylphenidate | Methylphenidate 27.5 mg/mg | PatchTransdermal | 0574-2410 | 00574-2410-65 | — |
| Methylphenidate Transdermal Systemmethylphenidate | Methylphenidate 41.3 mg/mg | PatchTransdermal | 0574-2415 | 00574-2415-65 | — |
| Methylphenidate Transdermal Systemmethylphenidate | Methylphenidate 82.5 mg/mg | PatchTransdermal | 0574-2430 | 00574-2430-65 | — |
| Lidocaine And Prilocaine | Lidocaine 25 mg/g; Prilocaine 25 mg/g | CreamTopical | 0574-2042 | 00574-2042-30 | — |
| Tobramycin And Dexamethasone | Tobramycin 3 mg/mL; Dexamethasone 1 mg/mL | Suspension/ dropsOphthalmic | 0574-4031 | 00574-4031-0500574-4031-1000574-4031-25 | — |
| Actidoseactivated charcoal | Activated charcoal 208 mg/mL | SuspensionOral | 0574-0520 | 00574-0520-7400574-0520-76 | — |
| Actidose Aquaactivated charcoal | Activated charcoal 208 mg/mL | SuspensionOral | 0574-0521 | 00574-0521-2500574-0521-7400574-0521-76 | — |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | 0574-0228 | 00574-0228-01 | — |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | 0574-0229 | 00574-0229-01 | — |
| budesonide | Budesonide 3 mg/1 | CapsuleOral | 0574-9855 | 00574-9855-10 | — |
| Paroxetine | Paroxetine mesylate 7.5 mg/1 | CapsuleOral | 0574-0279 | 00574-0279-30 | — |
| Tretinoin | Tretinoin .25 mg/g | CreamTopical | 0574-2225 | 00574-2225-2000574-2225-45 | — |
| Tretinoin | Tretinoin .5 mg/g | CreamTopical | 0574-2205 | 00574-2205-2000574-2205-45 | — |
| Tretinoin | Tretinoin .1 mg/g | GelTopical | 0574-2301 | 00574-2301-1500574-2301-45 | — |
| Tretinoin | Tretinoin 1 mg/g | CreamTopical | 0574-2201 | 00574-2201-2000574-2201-45 | — |
| Tretinoin | Tretinoin .25 mg/g | GelTopical | 0574-2325 | 00574-2325-1500574-2325-45 | — |
| hydromorphone hydrochloride | Hydromorphone hydrochloride 8 mg/1 | Tablet, Extended releaseOral | 0574-0293 | 00574-0293-01 | — |
| hydromorphone hydrochloride | Hydromorphone hydrochloride 12 mg/1 | Tablet, Extended releaseOral | 0574-0294 | 00574-0294-01 | — |
| hydromorphone hydrochloride | Hydromorphone hydrochloride 16 mg/1 | Tablet, Extended releaseOral | 0574-0295 | 00574-0295-01 | — |
| hydromorphone hydrochloride | Hydromorphone hydrochloride 32 mg/1 | Tablet, Extended releaseOral | 0574-0297 | 00574-0297-01 | — |
| Evamistestradiol | Estradiol 1.53 mg/1 | SprayTransdermal | 0574-2067 | 00574-2067-0000574-2067-27 | — |
| Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide | Brompheniramine maleate 2 mg/5mL + 2 more ingredients | SyrupOral | 0574-1104 | 00574-1104-0400574-1104-16 | — |
| methazolamide | Methazolamide 25 mg/1 | TabletOral | 0574-0790 | 00574-0790-01 | — |
| methazolamide | Methazolamide 50 mg/1 | TabletOral | 0574-0791 | — | — |
| Testosterone Cypionate | Testosterone cypionate 200 mg/mL | Injection, SolutionIntramuscular | 0574-0827 | 00574-0827-0100574-0827-10 | — |
| Bromocriptine mesylate | Bromocriptine mesylate 2.5 mg/1 | TabletOral | 0574-0106 | 00574-0106-0100574-0106-03 | — |
| Trospium Chloride ERtrospium chloride | Trospium chloride 60 mg/1 | Capsule, Extended releaseOral | 0574-0118 | 00574-0118-30 | — |
| acetylcysteine | Acetylcysteine 200 mg/mL | InjectionIntravenous | 0574-0805 | 00574-0805-30 | — |
| Trospium Chloride | Trospium chloride 20 mg/1 | Tablet, Film coatedOral | 0574-0145 | 00574-0145-60 | — |
| amiloride hydrochloride | Amiloride hydrochloride 5 mg/1 | TabletOral | 0574-0292 | 00574-0292-01 | — |
| Ciclopirox | Ciclopirox 7.7 mg/g | GelTopical | 0574-2061 | 00574-2061-0100574-2061-3000574-2061-45 | — |
| Testosterone Cypionate | Testosterone cypionate 200 mg/mL | Injection, SolutionIntramuscular | 0574-0820 | 00574-0820-0100574-0820-10 | — |
| Clotrimazole | Clotrimazole 10 mg/1 | LozengeOral | 0574-0107 | 00574-0107-1400574-0107-7000574-0107-77 | — |
| Midazolam Hydrochloride | Midazolam hydrochloride 2 mg/mL | SyrupOral | 0574-0150 | 00574-0150-04 | — |
| Flavoxate Hydrochloride | Flavoxate hydrochloride 100 mg/1 | Tablet, Film coatedOral | 0574-0115 | 00574-0115-01 | — |
| Podofilox | Podofilox 5 mg/mL | SolutionTopical | 0574-0611 | 00574-0611-05 | — |
| Comproprochlorperazine | Prochlorperazine 25 mg/1 | SuppositoryRectal | 0574-7226 | 00574-7226-12 | — |
Padagis US LLC: common questions
- What is Padagis US LLC's NDC labeler code?
- 0574. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Padagis US LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.